WELLS FARGO & COMPANY/MN

Position in NYXH — Nyxoah SA

CIK 72971 SAN FRANCISCO, CA

Position in NYXH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$591

+$362 QoQ

Shares Held

350

+1958.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 45 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $3,532,507,562 across 104 Medical Devices names. NYXH ranks #93 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	15,177,317	$1,377,189,742
2	SYK	Stryker Corp	2,407,680	$758,033,968
3	MDT	Medtronic plc	7,904,930	$618,402,670
4	BSX	Boston Scientific Corp	3,051,613	$130,242,842
5	EW	Edwards Lifesciences Corp	1,041,675	$94,229,919
6	GMED	Globus Medical Inc	996,617	$78,742,707
7	DXCM	Dexcom Inc	1,011,869	$68,149,375
8	GEHC	GE HealthCare Technologies Inc.	879,516	$56,297,816

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$591	350	+1958.8%	Shares	Defined	2026-08-14
2024-03-31	$229	17	0.0%	Shares	Defined	2024-05-10
2023-12-31	$78	17	0.0%	Shares	Defined	2024-02-09
2023-09-30	$119	17	0.0%	Shares	Defined	2023-11-13
2023-06-30	$136	17	0.0%	Shares	Defined	2023-08-15
2023-03-31	$126	17	0.0%	Shares	Defined	2023-05-12
2022-12-31	$84	17	0.0%	Shares	Defined	2023-02-13
2022-09-30	$107	17	-95.1%	Shares	Defined	2022-11-14
2022-06-30	$3,191	347	-98.8%	Shares	Defined	2022-08-12
2022-03-31	$543,402	28,391	+2.6%	Shares	Defined	2022-05-16
2021-12-31	$636,686	27,682	-83.1%	Shares	Defined	2022-02-14
2021-09-30	$4,787,352	163,687	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.